Literature DB >> 1486910

Diuretics and cardiovascular risk factors.

M Moser1.   

Abstract

Thiazide diuretics are efficacious, either as monotherapy or in combination with other antihypertensive drugs. They reduce blood pressure in a high percentage of hypertensive patients with minimal subjective side effects. There is increasing evidence that the use of diuretics, singly or in combination, will reduce morbidity and mortality associated with essential hypertension in both young and elderly subjects. Although diuretics may induce some changes in the plasma lipid profile, serum uric acid concentration and glucose metabolism, there is little evidence that these changes are of clinical significance. The increase in serum cholesterol concentration has rarely persisted in any trial beyond the first year of treatment. The incidence of diabetes mellitus in diuretic treated subjects is only about 1%, even when large doses are used. Gout may be precipitated in susceptible subjects, but is uncommon. For these reasons, diuretics should remain a preferred first-step drug of choice in the management of hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486910     DOI: 10.1093/eurheartj/13.suppl_g.72

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

Review 1.  Results of clinical trials with diuretics in heart failure.

Authors:  J R Hampton
Journal:  Br Heart J       Date:  1994-08

Review 2.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 3.  Postinfarct heart failure: role of diuretic therapy.

Authors:  J R Hampton
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

Review 4.  Antihypertensive therapy and sudden cardiac death, should we expect the unexpected?

Authors:  Elias Sanidas; Konstantinos Malliaras; Dimitrios Papadopoulos; Maria Velliou; Konstantinos Tsakalis; Kanella Zerva; John Barbetseas
Journal:  J Hum Hypertens       Date:  2020-01-14       Impact factor: 3.012

5.  Choosing initial antihypertensive drug therapy for the uncomplicated hypertensive patient.

Authors:  M A Moore
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jan-Feb       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.